Medpace Holdings (MEDP) Market Capitalization (2016 - 2026)
Medpace Holdings' (MEDP) quarterly Market Capitalization came in at $14.8 billion in Q2 2026, up 67.67% on a YoY basis from $8.8 billion in Q2 2025, and up 7.78% quarter-over-quarter from $13.7 billion in Q1 2026.
Analysis
Medpace Holdings (MEDP) Market Capitalization (2016 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Market Capitalization for 11 consecutive years, with $14.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization rose 67.67% year-over-year to $14.8 billion; the trailing twelve-month figure through Jun 2026 stood at $14.8 billion (up 67.67% YoY), and the FY2025 full-year result was $15.9 billion, up 56.58% from the prior year.
- Market Capitalization grew to $14.8 billion in Q2 2026 per MEDP's latest filing, from $13.7 billion in the prior quarter.
- Across five years, Market Capitalization topped out at $15.9 billion in Q4 2025 and bottomed at $4.6 billion in Q2 2022.
- Historically, Market Capitalization has averaged $9.7 billion across 5 years, with a median of $9.3 billion in 2023.
- The sharpest annual moves came in 2024 and 2025: Market Capitalization soared 117.44% in 2024, then sank 30.95% in 2025.
- Over 5 years, Market Capitalization stood at $6.6 billion in 2022, then soared by 42.74% to $9.4 billion in 2023, then grew by 7.96% to $10.2 billion in 2024, then soared by 56.58% to $15.9 billion in 2025, then declined by 7.24% to $14.8 billion in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $14.8 billion, $13.7 billion, and $15.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.78 Bn |
| Mar 31, 2026 | 13.71 Bn |
| Dec 31, 2025 | 15.93 Bn |
| Sep 30, 2025 | 14.48 Bn |
| Jun 30, 2025 | 8.82 Bn |
| Mar 31, 2025 | 9.09 Bn |
| Dec 31, 2024 | 10.18 Bn |
| Sep 30, 2024 | 10.38 Bn |
| Jun 30, 2024 | 12.77 Bn |
| Mar 31, 2024 | 12.52 Bn |
| Dec 31, 2023 | 9.43 Bn |
| Sep 30, 2023 | 7.43 Bn |
| Jun 30, 2023 | 7.34 Bn |
| Mar 31, 2023 | 5.76 Bn |
| Dec 31, 2022 | 6.60 Bn |
| Sep 30, 2022 | 4.89 Bn |
| Jun 30, 2022 | 4.64 Bn |
| Mar 31, 2022 | 5.51 Bn |
| Dec 31, 2021 | 7.84 Bn |
| Sep 30, 2021 | 6.80 Bn |